Issued Patents All Time
Showing 25 most recent of 82 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12415849 | Heterodimeric proteins | Matthew Bernett, Rumana Rashid, John Desjarlais | 2025-09-16 |
| 12378326 | Anti-CD28 x anti-PSMA antibodies | John Desjarlais, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng, Matthew Adam Dragovich +6 more | 2025-08-05 |
| 12378313 | Bispecific binding agents binding to CLDN18.2 and CD3 | Matthew Bernett, Alex Nisthal | 2025-08-05 |
| 12365743 | Anti-CD28 x anti-PSMA antibodies | John Desjarlais, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng, Matthew Adam Dragovich +6 more | 2025-07-22 |
| 12359002 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2025-07-15 |
| 12152076 | Bispecific and monospecific antibodies using novel anti-PD-1 sequences | Matthew Bernett, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal +1 more | 2024-11-26 |
| 12129309 | Heterodimeric antibodies that bind CD3 and CD38 | Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal | 2024-10-29 |
| 12054545 | Heterodimeric antibodies that bind somatostatin receptor 2 | Rumana Rashid, Sung-Hyung Lee, Paul Foster | 2024-08-06 |
| 12006345 | Untargeted and targeted IL-10 Fc-fusion proteins | Rajat Varma, Yoon Kyung Kim, Rumana Rashid, Alex Nisthal, Juan Diaz +2 more | 2024-06-11 |
| 11945880 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2024-04-02 |
| 11919958 | Anti-CD28 compositions | John Desjarlais, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng | 2024-03-05 |
| 11859011 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2024-01-02 |
| 11840579 | Bispecific antibodies that bind to CD38 and CD3 | Matthew Bernett, Seung Chu, John Desjarlais | 2023-12-12 |
| 11814423 | Heterodimeric proteins | Matthew Bernett, Rumana Rashid, John Desjarlais | 2023-11-14 |
| 11739145 | Bispecific binding agents binding to CLDN18.2 and CD3 | Matthew Bernett, Alex Nisthal | 2023-08-29 |
| 11718667 | Optimized antibody variable regions | Matthew Bernett, Rumana Rashid, John Desjarlais | 2023-08-08 |
| 11673972 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2023-06-13 |
| 11634506 | Heterodimeric proteins | Matthew Bernett, Rumana Rashid, John Desjarlais | 2023-04-25 |
| 11623957 | Heterodimeric antibodies that bind CD3 and PSMA | John Desjarlais, Seung Chu | 2023-04-11 |
| 11618776 | Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains | Matthew Bernett, John Desjarlais, Rajat Varma, Juan Diaz, Alex Nisthal +3 more | 2023-04-04 |
| 11591401 | Anti-CD28 compositions | John Desjarlais, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng | 2023-02-28 |
| 11530274 | Anti-STEAP1 antigen-binding protein | Olivier Nolan-Stevaux, Cong Li, Christopher Murawsky, Benjamin M. Alba, Neeraj Jagdish Agrawal +2 more | 2022-12-20 |
| 11492407 | Bispecific checkpoint inhibitor antibodies | Matthew Bernett, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal +1 more | 2022-11-08 |
| 11472890 | Heterodimeric antibodies that bind ENPP3 and CD3 | Rumana Rashid, Umesh Muchhal, Alex Nisthal, Seung Chu, Sung-Hyung Lee +1 more | 2022-10-18 |
| 11447552 | Methods and compositions for inhibiting CD32B expressing cells | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Igor Vostiar | 2022-09-20 |